Neurovascular Transduction During Exercise in Chronic Kidney Disease

A phase 2 trial registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 150 participants.

Also called NCT02947750

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; single masking; primary purpose supportive care
Phase
Phase 2
Enrolled
  • 150 participants (planned count) (from the registry)
Sponsor
Registry
  • NCT NCT02947750
Started
(actual) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
United States (from the registry)
Registry status
  • Recruiting (from the registry)

Technical summary

Registry record NCT02947750. Randomized; single masking; primary purpose supportive care. Start 2016-10 (actual); primary completion 2027-04-30 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Neurovascular Transduction During Exercise in Chronic Kidney Disease
Acronym
NeurovEx
Condition
Renal Insufficiency, Chronic
Intervention (Drug)
6R-BH4
Intervention (Other)
6R-BH4 placebo
Intervention (Dietary supplement)
Folic acid
Intervention (Other)
Exercise training
Intervention (Other)
Stretching
Intervention (Dietary supplement)
Histidine and beta-alanine supplementation
Intervention (Other)
Histidine and beta-alanine placebo
Lead sponsor
Emory University (class: other)
Collaborator
National Heart, Lung, and Blood Institute (NHLBI) (class: US National Institutes of Health)

Record details

Record id
cardio:ct-nct02947750
Content hash
b6ed6a056ba977c372a0617083011b99792102f8d1f8cedb38cded33fc913d80